Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 800.37
+4.73 (0.59%)
At close: Mar 15, 2026
EGX:AXPH Revenue
Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 917.50M EGP in the quarter ending December 31, 2025, with 17.23% growth. This brings the company's revenue in the last twelve months to 3.02B, up 29.25% year-over-year. In the fiscal year ending June 30, 2025, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 2.75B with 55.56% growth.
Revenue (ttm)
3.02B
Revenue Growth
+29.25%
P/S Ratio
1.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.75B | 982.44M | 55.56% |
| Jun 30, 2024 | 1.77B | 283.76M | 19.12% |
| Jun 30, 2023 | 1.48B | 384.31M | 34.94% |
| Jun 30, 2022 | 1.10B | -4.24M | -0.38% |
| Jun 30, 2021 | 1.10B | 79.44M | 7.75% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition